(Q72678236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Single-agent and combination chemotherapy with etoposide in the acute leukemias of childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(82)80078-9

22 August 2023

author name string

G. Rivera

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

W. P. Bowman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

A. T. Look

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

W. E. Evans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

D. Kalwinsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

G. V. Dahl

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6181873

22 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6181873

22 August 2023

publication date

1 June 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

https://api.elsevier.com/content/article/PII:S0305737282800789?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(82)80078-9

https://api.elsevier.com/content/article/PII:S0305737282800789?httpAccept=text/plain

22 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(82)80078-9

22 August 2023

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

9 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

53-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives

28 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas, and lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

VM 26 and VP 16-213: a comparative analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

5-azacytidine in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

VP 16-213 in acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

4′-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2882%2980078-9

7 January 2021

Childhood acute lymphocytic leukemia: progress and problems in treatment

2

1 reference

https://api.crossref.org/works/10.1016/S0305-7372(82)80078-9

22 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6181873%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference